ABSTRACT
We report on the results obtained with the global CUPID-0 background model, which combines the data collected in the two measurement campaigns for a total exposure of 8.82 kg×yr of ^{82}Se. We identify with improved precision the background sources within the 3 MeV energy region, where neutrinoless double ß decay of ^{82}Se and ^{100}Mo is expected, making more solid the foundations for the background budget of the next-generation CUPID experiment. Relying on the excellent data reconstruction, we measure the two-neutrino double ß-decay half-life of ^{82}Se with unprecedented accuracy: T_{1/2}^{2ν}=[8.69±0.05(stat)_{-0.06}^{+0.09}(syst)]×10^{19} yr.
ABSTRACT
This corrects the article DOI: 10.1103/PhysRevLett.126.171801.
ABSTRACT
Objetivo: El infarto agudo de miocardio con elevación del segmento ST (IAMCEST) requiere un tratamiento precoz y resolutivo. El objetivo de este estudio observacional retrospectivo fue medir la diferencia entre los intervalos temporales desde el inicio de los síntomas y el primer contacto médico (PCM) hasta el inflado de balón. Método: Se recogieron los registros consecutivos de todos los pacientes con IAMCEST que fueron derivados al laboratorio de hemodinámica (LbH) para ser tratados con angioplastia primaria (ACTPp), durante un periodo de 12 meses. Los pacientes se dividieron en dos grupos: grupo A, derivados a LbH desde los sistemas de emergencias médicas (SEM), directamente o a través del servicio de urgencias hospitalario (SUH); y grupo B pacientes que acuden por sus propios medios al SUH. La duración del proceso se calculó en dos intervalos, desde el inicio de síntomas (T1) hasta el inflado de balón y (..) (AU)
Introduction: ST-elevation myocardial infarction (STEMI) must be treated early and aggressively. The aim of this retropective observational study was to measure the times from first medical contact (FMC) to balloon inflation and from symptom onset to balloon inflation. Methods: The consecutive records of all the patients who underwent a primary percutaneous coronary intervention (PCI) for STEMI in the catheterization laboratory over a 12-month period were included. Patients were classified as group A if emergency medical responders brought them directly to the catheterization laboratory or to the emergency department, or group B if they were self-presenters to the emergency department. The duration of the process was calculated in 2 ways, from symptom onset (T1) to balloon inflation and from FMC (T2) to balloon inflation. Relevant medical history and hospital and 30-day (..) (AU)